Cell Death

Introduction

Cell death is not merely a failure of cellular machinery — it is one of the most tightly regulated processes in biology. During human embryonic development, programmed cell death sculpts fingers by removing the webbing between digits, eliminates self-reactive immune cells that could cause autoimmunity, and removes transient structures like the tail of the tadpole-stage embryo. In the adult human body, roughly 50–70 billion cells die each day through controlled death programs, precisely balancing the production of new cells by mitosis to maintain tissue homeostasis.

Cells die by multiple mechanisms, and the choice of death pathway has profound consequences for the surrounding tissue. Apoptosis is clean and non-inflammatory, quietly dismantling a cell and packaging its contents for phagocytic disposal. Necroptosis, pyroptosis, and ferroptosis are inflammatory or immunogenic forms of death that alert the immune system to danger. Each pathway uses distinct molecular machinery and is activated in different biological contexts. Understanding these pathways is essential for modern medicine: too little cell death enables cancer, too much causes degenerative disease, and the specific mode of death determines whether the immune system is activated or suppressed.

This lesson covers the major cell death mechanisms — apoptosis (intrinsic and extrinsic pathways), necroptosis, pyroptosis, and ferroptosis — their molecular regulation, their roles in health and disease, and the computational tools used to analyze cell death pathways from genomic and transcriptomic data.

18.1 — Overview of Cell Death Mechanisms

Apoptosis Eliminates Unwanted Cells

Apoptosis (from Greek, meaning “falling off,” like leaves from a tree) is the best-understood and most prevalent form of programmed cell death in animals. It eliminates cells that are damaged, infected, potentially dangerous, or simply no longer needed. Apoptosis is characterized by a distinctive sequence of morphological changes:

1. The cell shrinks and its chromatin condenses (pyknosis)
2. The nucleus fragments (karyorrhexis)
3. The cytoplasm and organelles are packaged into membrane-enclosed apoptotic bodies
4. Phosphatidylserine is exposed on the outer leaflet of the plasma membrane, serving as an “eat me” signal
5. Phagocytes rapidly engulf the apoptotic bodies before any cellular contents leak out

Because the cell is dismantled without releasing its contents, apoptosis is non-inflammatory — a critical distinction from necrotic forms of death.

The Caspase Cascade

Apoptosis depends on an intracellular proteolytic cascade mediated by a family of cysteine proteases called caspases (cysteine-aspartate proteases). Caspases are synthesized as inactive procaspases (zymogens) that are activated by proteolytic cleavage. They cleave their substrates after aspartate residues, and once activated, they cleave and activate other caspases in an amplifying cascade.

Caspases fall into two functional classes:

Executioner caspases cleave structural proteins (lamins, cytoskeletal proteins), DNA repair enzymes, and activate CAD (caspase-activated DNase), which fragments the genomic DNA into the characteristic nucleosomal “ladder” pattern visible on gel electrophoresis. The two major pathways that activate this cascade — intrinsic and extrinsic — converge on the same executioner caspases.

The Intrinsic (Mitochondrial) Pathway

The intrinsic pathway of apoptosis depends on proteins released from mitochondria. It is triggered by internal stress signals: DNA damage, oncogene activation, growth factor withdrawal, endoplasmic reticulum stress, or viral infection. The central event is the permeabilization of the outer mitochondrial membrane, which releases several pro-apoptotic proteins from the intermembrane space into the cytoplasm:

1. Cytochrome c is released from the mitochondrial intermembrane space
2. Cytochrome c binds Apaf-1 (apoptotic protease-activating factor 1) in the cytoplasm
3. Apaf-1 oligomerizes into a large wheel-shaped complex called the apoptosome (seven Apaf-1 molecules forming a heptameric ring)
4. The apoptosome recruits and activates the initiator caspase-9
5. Active caspase-9 cleaves and activates the executioner caspase-3 and caspase-7
6. Executioner caspases systematically dismantle the cell

Additional proteins released from mitochondria include Smac/DIABLO and Omi/HtrA2, which promote apoptosis by neutralizing caspase inhibitors (IAPs, discussed below).

Bcl-2 Family Proteins Regulate the Intrinsic Pathway

The critical decision of whether to permeabilize the mitochondrial outer membrane is controlled by the Bcl-2 family of proteins, named after the first member discovered in B-cell lymphoma. This family contains both pro-death and pro-survival members that physically interact to determine cell fate:

The BH3-only proteins act as sentinels that detect specific stress signals: PUMA and Noxa are transcriptionally induced by p53 in response to DNA damage; Bad is activated when survival factor signaling ceases; Bid is cleaved by caspase-8, linking the extrinsic pathway to mitochondrial amplification. Some BH3-only proteins directly activate Bax/Bak (the “activators” — Bid, Bim), while others sequester the anti-apoptotic proteins away from Bax/Bak (the “sensitizers” — Bad, Noxa).

The balance between pro- and anti-apoptotic Bcl-2 family members determines whether a cell lives or dies. Cells with high levels of Bcl-2 or Bcl-X_L are resistant to apoptosis; those with elevated BH3-only proteins are primed for death.

The Extrinsic (Death Receptor) Pathway

The extrinsic pathway of apoptosis is activated by extracellular ligands that bind to death receptors on the cell surface. This pathway enables one cell to instruct another to die — essential for immune surveillance, where cytotoxic T lymphocytes and natural killer cells eliminate infected or cancerous target cells.

The pathway proceeds as follows:

1. Death ligands (FasL, TNF, TRAIL) bind their corresponding death receptors (Fas/CD95, TNFR1, DR4/DR5) on the target cell
2. The receptor’s intracellular death domain (DD) recruits the adaptor protein FADD (Fas-associated death domain protein)
3. FADD recruits procaspase-8 (or procaspase-10) through its death effector domain (DED), forming the DISC (death-inducing signaling complex)
4. Procaspase-8 molecules are brought into close proximity, triggering their autocatalytic activation
5. Active caspase-8 directly cleaves and activates executioner caspases-3 and -7

In some cell types (called type I cells, such as thymocytes), caspase-8 alone generates enough executioner caspase activity to kill the cell. In other cell types (called type II cells, such as hepatocytes), caspase-8 also cleaves the BH3-only protein Bid to generate tBid (truncated Bid), which activates the mitochondrial pathway to amplify the death signal. This crosstalk between the extrinsic and intrinsic pathways ensures robust cell killing.

IAPs Help Control Caspases

Inhibitor of Apoptosis Proteins (IAPs) are a family of intracellular proteins that directly bind and inhibit caspases, serving as a safety brake against accidental caspase activation. The most important mammalian IAPs are XIAP, cIAP1, and cIAP2. XIAP directly inhibits caspase-3, caspase-7, and caspase-9 by binding to their active sites or preventing their dimerization.

IAPs are themselves regulated by antagonists: the mitochondrial proteins Smac/DIABLO and Omi/HtrA2, released during the intrinsic pathway, bind IAPs and relieve their inhibition of caspases. This ensures that once the mitochondrial “point of no return” has been crossed, the caspase cascade proceeds to completion.

Extracellular Survival Factors Inhibit Apoptosis

Cells in a multicellular organism do not survive autonomously — they depend on extracellular survival factors (growth factors, cytokines, cell-matrix interactions) that continuously suppress the apoptotic machinery. This creates a default-death program: unless a cell receives positive survival signals, it undergoes apoptosis. This mechanism ensures that cells only survive in their proper location and context.

Survival factors inhibit apoptosis through several routes:

• PI3K/Akt signaling: Akt phosphorylates and inactivates the pro-apoptotic BH3-only protein Bad, preventing it from neutralizing Bcl-2/Bcl-X_L
• Ras/MAPK signaling: ERK phosphorylates and stabilizes Mcl-1, an anti-apoptotic Bcl-2 family member
• NF-κB activation: induces transcription of anti-apoptotic genes including Bcl-2, Bcl-X_L, cIAP1, and cIAP2
• Transcriptional regulation: survival signals suppress expression of BH3-only proteins like Bim and PUMA

When survival signals are withdrawn — for example, when a cell detaches from its normal tissue context — the balance tips toward apoptosis. This phenomenon, called anoikis, prevents detached cells from surviving in inappropriate locations and is a key barrier to metastasis in cancer.

Phagocytes Remove Apoptotic Cells

The final step of apoptosis is the rapid and efficient removal of dying cells by phagocytes (macrophages and, in some tissues, neighboring epithelial cells or fibroblasts). Apoptotic cells display “eat me” signals — most importantly phosphatidylserine on the outer leaflet of the plasma membrane (normally restricted to the inner leaflet in healthy cells). Phagocytes recognize phosphatidylserine through receptors like Tim-4 and BAI1, or indirectly through bridging molecules like MFG-E8 and Gas6 that link phosphatidylserine to phagocyte integrins.

Phagocytic clearance must be rapid to prevent secondary necrosis (leakage of cell contents), which would trigger inflammation. Apoptotic cells also release “find me” signals (ATP, UTP, lysophosphatidylcholine) that recruit phagocytes, and they downregulate “don’t eat me” signals (CD47) to facilitate engulfment.

Cell Death Pathway Analysis: Bioinformatics Approaches

The complexity of cell death regulation has motivated the development of extensive computational resources:

Apoptosis gene sets and pathway databases — curated databases like the KEGG apoptosis pathway, Reactome, and the Cell Death Regulation collection in MSigDB contain annotated gene sets for each death pathway. These gene sets are used in gene set enrichment analysis (GSEA) to determine whether a given transcriptomic dataset shows activation of specific cell death programs.

Caspase substrate prediction — databases like CaspDB and DegraBase catalog experimentally verified caspase cleavage sites in protein substrates. CaspDB organizes caspase substrates by the specific caspase that cleaves them and the cleavage site sequence motif. Computational tools use position-specific scoring matrices (PSSMs) derived from known cleavage sites to predict novel caspase substrates from protein sequence alone.

Bcl-2 family interaction modeling — the specificity of BH3-only protein interactions with anti-apoptotic Bcl-2 members determines which stress signals are neutralized. Computational modeling of these protein-protein interactions, using structures from the PDB, helps predict how perturbation of one family member shifts the pro-death/pro-survival balance.

Cell death classification from transcriptomic data — machine learning classifiers trained on expression signatures of apoptosis, necroptosis, pyroptosis, and ferroptosis can classify the predominant cell death mode in experimental or clinical samples. This is especially useful in tumor samples where multiple death pathways may be simultaneously active.

Let us examine caspase active sites computationally. Human caspases share a conserved catalytic cysteine but differ in the surrounding residues that determine substrate specificity. We can compare the active site pentapeptides of key caspases from the intrinsic and extrinsic pathways:

let caspase3_active = "QACRG"
let caspase8_active = "QACQG"
let caspase9_active = "QACGG"
print("Caspase-3 active site (executioner):")
print(Struct.protein_props(caspase3_active))
print("Caspase-8 active site (initiator, extrinsic):")
print(Struct.protein_props(caspase8_active))
print("Caspase-9 active site (initiator, intrinsic):")
print(Struct.protein_props(caspase9_active))

Despite both being cysteine proteases with similar catalytic mechanisms, the initiator and executioner caspases show limited sequence similarity outside the conserved catalytic residues, reflecting their distinct substrate specificities and activation mechanisms.

18.2 — Necrosis and Necroptosis

Necrosis Can Be Regulated

For decades, necrosis was considered purely accidental — the uncontrolled death of cells overwhelmed by physical trauma, extreme heat, or toxins. Necrotic cells swell, their membranes rupture, and they spill their intracellular contents into the surrounding tissue, provoking inflammation. However, research over the past two decades has revealed that some forms of necrosis are in fact regulated by specific signaling pathways. The most well-characterized is necroptosis.

RIPK1 and RIPK3 Mediate Necroptosis

Necroptosis is a programmed form of necrotic cell death that is activated when caspase-8 is inhibited or absent. The key signaling components are the receptor-interacting protein kinases RIPK1 and RIPK3, and the pseudokinase MLKL (mixed lineage kinase domain-like protein).

The canonical necroptosis pathway is triggered by TNF signaling:

1. TNF binds TNFR1, recruiting RIPK1 through its death domain
2. Under normal conditions, RIPK1 is ubiquitinated and participates in NF-κB pro-survival signaling
3. When ubiquitination is blocked (by Smac mimetics or loss of cIAPs), RIPK1 is deubiquitinated and forms a cytoplasmic complex
4. If caspase-8 is active, it cleaves RIPK1, directing the cell toward apoptosis
5. If caspase-8 is inhibited (e.g., by viral caspase inhibitors like CrmA, or by synthetic pan-caspase inhibitors), RIPK1 binds RIPK3 through their shared RHIM (RIP homotypic interaction motif) domains
6. RIPK1 and RIPK3 form the necrosome — an amyloid-like signaling platform
7. RIPK3 phosphorylates MLKL, causing MLKL to oligomerize
8. MLKL oligomers translocate to the plasma membrane, forming pores that disrupt membrane integrity
9. The cell swells and lyses, releasing DAMPs (damage-associated molecular patterns) — including HMGB1, ATP, and mitochondrial DNA — into the surrounding tissue

Necroptosis and Inflammation

The release of DAMPs from necroptotic cells has potent immunological consequences. DAMPs activate pattern recognition receptors on neighboring immune cells (TLRs, RAGE, P2X7), triggering pro-inflammatory cytokine production and immune cell recruitment. Necroptosis therefore serves as an alarm system: when apoptosis is blocked (as it often is during viral infection, since many viruses encode caspase inhibitors), necroptosis ensures that the infected cell still dies and, critically, alerts the immune system in the process.

This creates a cell death decision tree: the default response to a death signal is apoptosis (clean, quiet). Only when apoptosis is blocked does necroptosis engage (messy, inflammatory). This backup system is an important innate immune defense, particularly against viruses that have evolved to suppress apoptosis.

18.3 — Other Forms of Regulated Cell Death

Pyroptosis Is Driven by Inflammasome-Activated Gasdermins

Pyroptosis (from Greek pyro, fire or fever) is a highly inflammatory form of cell death that is activated by intracellular danger signals, particularly during infection by intracellular pathogens. The pathway is driven by inflammasomes and executed by gasdermin family proteins.

The pyroptosis pathway:

1. Intracellular pattern recognition receptors (e.g., NLRP3, NLRC4, AIM2) detect pathogen-associated molecular patterns (PAMPs) or danger-associated molecular patterns (DAMPs)
2. The sensor protein oligomerizes and recruits the adaptor ASC, forming a large, multi-protein inflammasome complex
3. The inflammasome activates caspase-1 (the “inflammatory caspase”) through proximity-induced autoactivation
4. Active caspase-1 cleaves gasdermin D (GSDMD), liberating its N-terminal domain
5. The N-terminal fragment of GSDMD oligomerizes in the plasma membrane, forming large pores (~18 nm inner diameter)
6. These pores release mature IL-1β and IL-18 (which were also cleaved to their active forms by caspase-1) and other cytosolic contents
7. The cell swells osmotically and lyses

The gasdermin family comprises six members in humans (GSDMA-E, PEJVAKIN). All share a similar architecture: an N-terminal pore-forming domain that is autoinhibited by the C-terminal domain. Cleavage by inflammatory caspases (or, in some cases, by granzymes from cytotoxic lymphocytes) releases the pore-forming domain. Different family members are activated in different contexts — GSDME, for example, is cleaved by caspase-3 (an executioner of apoptosis), converting apoptosis into pyroptosis in cells that express GSDME.

Pyroptosis is a critical defense against intracellular bacteria (such as Salmonella, Shigella, and Legionella) that replicate inside cells. By lysing the infected cell and releasing pro-inflammatory cytokines, pyroptosis exposes the bacteria to extracellular immune defenses. However, excessive pyroptosis can also drive pathological inflammation, as in sepsis and autoinflammatory diseases.

Ferroptosis Depends on Iron-Catalyzed Lipid Peroxidation

Ferroptosis (from Latin ferrum, iron) is a recently discovered form of regulated cell death driven by the accumulation of iron-dependent lipid peroxides in cellular membranes. Unlike apoptosis (caspase-dependent) and necroptosis (RIPK-dependent), ferroptosis does not require proteases or kinases of the canonical death machinery.

The molecular basis of ferroptosis:

• Polyunsaturated fatty acids (PUFAs) in membrane phospholipids are susceptible to oxidation
• Free iron (Fe²⁺) catalyzes the Fenton reaction (Fe²⁺ + H⊂2;O⊂2; → Fe³⁺ + OH• + OH−), generating hydroxyl radicals that initiate lipid peroxidation chain reactions
• The cell’s primary defense is the glutathione-GPX4 axis: GPX4 (glutathione peroxidase 4) reduces toxic lipid hydroperoxides to non-toxic lipid alcohols, using glutathione (GSH) as a cofactor
• Glutathione synthesis requires cysteine, imported via the system x_c− antiporter (SLC7A11)
• When GPX4 activity is lost (by direct inhibition, glutathione depletion, or cysteine deprivation), lipid peroxides accumulate uncontrollably
• Peroxidized membranes lose integrity, and the cell dies

Key regulators of ferroptosis:

Ferroptosis is implicated in neurodegeneration (Alzheimer’s, Parkinson’s), ischemia-reperfusion injury (stroke, myocardial infarction), and acute kidney injury. Conversely, therapy-resistant cancer cells — particularly those that have undergone epithelial-mesenchymal transition (EMT) — may be unusually vulnerable to ferroptosis inducers, opening a potential therapeutic window.

Additional Cell Death Programs Continue to Be Discovered

The cell death field is rapidly expanding. Additional regulated cell death programs include:

• Parthanatos — driven by hyperactivation of PARP-1, NAD⁺ depletion, and AIF release from mitochondria
• Cuproptosis — driven by copper-dependent aggregation of mitochondrial lipoylated proteins
• NETosis — neutrophil-specific death involving the extrusion of neutrophil extracellular traps (NETs)
• Entosis — live-cell engulfment of one cell by another

These pathways highlight the remarkable diversity of death mechanisms available to cells. The Nomenclature Committee on Cell Death (NCCD) periodically publishes updated guidelines to classify these forms of regulated cell death based on their molecular mechanisms.

Regulated Cell Death Bioinformatics

Computational tools and databases are essential for navigating the complexity of cell death pathways:

Ferroptosis gene and pathway databases — resources like FerrDb curate lists of ferroptosis drivers, suppressors, and markers, linking them to experimental evidence. These gene sets can be used in pathway enrichment analysis to assess ferroptosis activation in transcriptomic data.

Pyroptosis pathway analysis and gasdermin family classification — computational phylogenetics classifies the gasdermin family across species, revealing the evolutionary expansion of this family in mammals. Sequence alignment of gasdermin N-terminal domains identifies conserved residues required for pore formation.

Pan-cell-death gene expression signatures — integrated analyses of transcriptomic datasets from cells undergoing different forms of death have identified gene expression signatures specific to each mode. These signatures enable classification of the predominant cell death mode in clinical samples (e.g., tumor biopsies, inflammatory lesions).

Drug–cell death mechanism association analysis — pharmacogenomic databases like the GDSC (Genomics of Drug Sensitivity in Cancer) and PRISM link drug sensitivity to expression of cell death regulators. For example, cells with low GPX4 expression may be predicted to be sensitive to ferroptosis inducers, while cells with high Bcl-2 expression may be targeted with BH3 mimetics.

Let us examine the Bcl-2 family BH3 domains, which mediate the critical protein-protein interactions that determine whether a cell lives or dies:

let bcl2_bh3 = "LRQKGDEGALAMR"
let bax_bh3 = "LKRIGDELDSNMELQRMIAD"
let bid_bh3 = "IIRNIARHLAQVGDSMDR"
print("Bcl-2 BH3 domain (anti-apoptotic):")
print(Struct.protein_props(bcl2_bh3))
print("Bax BH3 domain (pro-apoptotic):")
print(Struct.protein_props(bax_bh3))
print("Bid BH3 domain (BH3-only sensor):")
print(Struct.protein_props(bid_bh3))

The BH3 domains of pro- and anti-apoptotic family members compete for binding: anti-apoptotic Bcl-2 sequesters BH3-only proteins and Bax/Bak, while BH3-only sensors displace this inhibition when stress signals accumulate.

We can also visualize how different stress signals vary in their ability to trigger apoptosis:

let threshold_data = '[{"label": "DNA damage (low)", "value": 20}, {"label": "DNA damage (high)", "value": 90}, {"label": "Growth factor withdrawal", "value": 65}, {"label": "Death ligand (FasL)", "value": 85}, {"label": "ER stress", "value": 45}]'
let chart = Viz.bar(threshold_data, '{"title": "Apoptosis Activation (% cells)", "color": "#EF4444"}')
print(chart)

Exercise: Classify Bcl-2 Family Members

The Bcl-2 family includes pro-apoptotic and anti-apoptotic members. Their BH3 domains mediate critical protein-protein interactions. Analyze these domains to understand the competition:

let bcl2 = "LRQKGDEGALAMR"
let bax = "LKRIGDELDSNMELQRMIAD"
let bad = "NLWAAQRYGRELRRMSD"
print("Bcl-2 BH3 (anti-apoptotic):")
print(Struct.protein_props(bcl2))
print("Bax BH3 (pro-apoptotic effector):")
print(Struct.protein_props(bax))
print("Bad BH3 (pro-apoptotic sensor):")
print(Struct.protein_props(bad))
// Which protein directly permeabilizes the mitochondrial membrane?
let answer = "Bax"
print(answer)

Exercise: Apoptotic Threshold

Cells don’t die from every stress — apoptosis requires the stress signal to exceed a threshold set by the balance of pro- and anti-apoptotic Bcl-2 family members. Visualize how changing Bcl-2 levels affects the threshold:

let normal = '[{"label": "Low stress", "value": 5}, {"label": "Medium stress", "value": 45}, {"label": "High stress", "value": 85}]'
let high_bcl2 = '[{"label": "Low stress", "value": 2}, {"label": "Medium stress", "value": 10}, {"label": "High stress", "value": 30}]'
print("Normal Bcl-2 levels:")
print(Viz.bar(normal, '{"title": "Apoptosis (%) - Normal", "color": "#3B82F6"}'))
print("Bcl-2 overexpressed:")
print(Viz.bar(high_bcl2, '{"title": "Apoptosis (%) - High Bcl-2", "color": "#EF4444"}'))
// In which condition is the cell resistant to apoptosis?
let answer = "overexpressed"
print(answer)

Exercise: Caspase Activation Cascade

Caspases are activated in a specific order — initiator caspases activate executioner caspases, which cleave cellular substrates. Analyze the substrate specificity of different caspases through their active site properties:

let casp3 = "QACRG"
let casp8 = "QACQG"
let casp9 = "QACGG"
print("Caspase-3 (executioner):")
print(Struct.protein_props(casp3))
print("Caspase-8 (initiator):")
print(Struct.protein_props(casp8))
print("Caspase-9 (initiator):")
print(Struct.protein_props(casp9))
// Which caspase directly cleaves cellular substrates (PARP, lamins)?
let answer = "caspase-3"
print(answer)

18.4 — Cell Death in Health and Disease

Excessive or Insufficient Cell Death Contributes to Disease

The balance between cell survival and cell death is critical for health. When this balance is disrupted, disease follows:

Too little cell death (insufficient apoptosis):

• Cancer — tumor cells evade apoptosis through overexpression of anti-apoptotic proteins (Bcl-2, Bcl-X_L, Mcl-1), loss of pro-apoptotic regulators (p53, Bax), or upregulation of IAPs. Resistance to apoptosis is one of the hallmarks of cancer
• Autoimmune disease — failure to eliminate self-reactive lymphocytes during development leads to immune cells that attack the body’s own tissues (e.g., autoimmune lymphoproliferative syndrome from Fas/FasL mutations)
• Viral persistence — viruses that express caspase inhibitors or Bcl-2 homologs can prevent death of infected cells

Too much cell death (excessive apoptosis or other death modes):

• Neurodegenerative disease — excessive neuronal death in Alzheimer’s disease (involving ferroptosis and apoptosis), Parkinson’s disease, and ALS
• Ischemia-reperfusion injury — tissue death following stroke or heart attack involves multiple death pathways (apoptosis, necroptosis, ferroptosis)
• Sepsis — excessive pyroptosis and cytokine release drive organ failure
• AIDS — HIV infection causes apoptosis of CD4⁺ T cells, destroying the immune system

Drugs Targeting Apoptosis Are Used in Cancer Treatment

The understanding of cell death pathways has led to the development of targeted therapeutics, particularly for cancer:

BH3 mimetics — small molecules that mimic BH3-only proteins and bind anti-apoptotic Bcl-2 family members, displacing pro-apoptotic proteins and triggering apoptosis. Venetoclax (ABT-199) is a selective Bcl-2 inhibitor approved for chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). It exploits the dependence of CLL cells on Bcl-2 for survival — a vulnerability termed oncogene addiction. Venetoclax was the first BH3 mimetic to gain FDA approval and represents the clinical validation of decades of Bcl-2 biology research.

Smac mimetics — small molecules that mimic the IAP-binding motif of Smac/DIABLO, antagonizing cIAP1/2 and XIAP. By degrading cIAPs, they simultaneously sensitize cells to apoptosis and, in some contexts, redirect TNF signaling toward necroptosis. Several Smac mimetics are in clinical trials.

Death receptor agonists — recombinant TRAIL or agonistic antibodies against DR4/DR5 can selectively trigger apoptosis in cancer cells while sparing most normal cells (which are resistant due to decoy receptors and high FLIP expression). Clinical development has been challenging, but next-generation TRAIL receptor agonists with improved potency are in development.

RIPK1 inhibitors — for diseases driven by necroptosis-mediated inflammation, inhibitors of RIPK1 kinase activity (e.g., necrostatin-1 and clinical derivatives) are being explored for inflammatory bowel disease, neuroinflammation, and ischemic injury.

Ferroptosis modulators — ferroptosis inducers (erastin, RSL3) are being investigated for therapy-resistant cancers, while ferroptosis inhibitors (ferrostatin-1, liproxstatin-1) may protect against neurodegeneration and ischemia-reperfusion injury.

Knowledge Check

Summary

In this lesson you covered the major pathways of cell death and their biological significance:

• Cells die by multiple regulated mechanisms — the choice of pathway determines whether death is clean (apoptosis) or inflammatory (necroptosis, pyroptosis)
• Apoptosis is mediated by caspases in two converging pathways: the intrinsic (mitochondrial) pathway (cytochrome c → Apaf-1 → apoptosome → caspase-9) and the extrinsic (death receptor) pathway (death ligands → FADD → DISC → caspase-8)
• Bcl-2 family proteins regulate the intrinsic pathway: anti-apoptotic members (Bcl-2, Bcl-X_L) inhibit Bax/Bak pore formation; BH3-only proteins sense stress and activate the pathway
• IAPs inhibit caspases and are antagonized by Smac/DIABLO released from mitochondria
• Extracellular survival factors (growth factors, cytokines) continuously suppress apoptosis through PI3K/Akt, MAPK, and NF-κB signaling
• Phagocytes rapidly clear apoptotic cells via phosphatidylserine recognition, preventing inflammation
• Necroptosis is mediated by RIPK1/RIPK3/MLKL when caspase-8 is inhibited; it serves as an inflammatory backup to apoptosis, especially during viral infection
• Pyroptosis is driven by inflammasome-activated caspase-1, which cleaves gasdermin D to form membrane pores that release IL-1β and IL-18
• Ferroptosis depends on iron-catalyzed lipid peroxidation when the GPX4 antioxidant defense fails
• Additional death programs (parthanatos, cuproptosis, NETosis) continue to be discovered
• Dysregulated cell death underlies cancer (insufficient death), neurodegeneration (excessive death), sepsis (excessive pyroptosis), and autoimmune disease
• Targeted therapeutics include BH3 mimetics (venetoclax), Smac mimetics, death receptor agonists, RIPK1 inhibitors, and ferroptosis modulators
• Bioinformatics tools for cell death include CaspDB, FerrDb, pathway enrichment analysis, gasdermin phylogenetics, pan-cell-death signatures, and drug–cell death association databases